Cormorant Asset Management, LP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q4 2020$21,229,000
+38.6%
650,000
+30.0%
0.50%
-14.3%
Q3 2020$15,320,000
+34.3%
500,000
-28.6%
0.59%
+35.4%
Q2 2020$11,410,000
+43.3%
700,000
-12.5%
0.44%
+17.6%
Q1 2020$7,960,000
-42.1%
800,000
-20.0%
0.37%
-32.6%
Q4 2019$13,750,000
-26.4%
1,000,000
-18.8%
0.55%
-51.7%
Q3 2019$18,682,000
-32.2%
1,231,500
-12.0%
1.14%
-28.2%
Q2 2019$27,566,000
+18.7%
1,400,0000.0%1.58%
+0.8%
Q1 2019$23,226,000
+200.8%
1,400,000
+154.5%
1.57%
+150.4%
Q4 2018$7,722,000550,0000.63%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders